About Artemis Therapeutics
Artemis Therapeutics is a company based in New York (United States) founded in 2017. It operates as a B2B. Artemis Therapeutics offers products and services including Cameo Library and Pathway Predictor. Artemis Therapeutics operates in a competitive market with competitors including Jaguar Health, 60 Degrees Pharmaceuticals, MalarVx, Vyera Pharmaceuticals and ACE Pharmaceuticals, among others.
- Headquarter New York, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name New York Global Innovations Inc.
-
Annual Revenue
$311 K (USD)0as on Dec 31, 2022
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Artemis Therapeutics
Artemis Therapeutics offers a comprehensive portfolio of products and services, including Cameo Library and Pathway Predictor.
Python library for computing strain designs
Tool for predicting heterologous pathways in chemicals
Funding Insights of Artemis Therapeutics
Detailed funding history for Artemis Therapeutics
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Artemis Therapeutics
Investment portfolio details for Artemis Therapeutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Artemis Therapeutics
Detailed financials for Artemis Therapeutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Artemis Therapeutics Comparisons
Peer comparison for Artemis Therapeutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Artemis Therapeutics
Artemis Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jaguar Health, 60 Degrees Pharmaceuticals, MalarVx, Vyera Pharmaceuticals and ACE Pharmaceuticals, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Novel gastrointestinal products for humans and animals are developed sustainably.
|
|
| Locked | Locked | Locked |
Medicines for the treatment and prevention of tropical diseases including dengue, malaria
|
|
| Locked | Locked | Locked |
Developing vaccines for Malaria
|
|
| Locked | Locked | Locked |
Delivers comprehensive small molecule therapeutics for toxoplasmosis and neglected parasitic infections.
|
|
| Locked | Locked | Locked |
Drugs are manufactured for sister companies in the Netherlands.
|
|
| Locked | Locked | Locked |
Develops and commercializes antibodies for preventing gastrointestinal infections during travel.
|
Detailed competitors of Artemis Therapeutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Artemis Therapeutics
Complete news archive for Artemis Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Artemis Therapeutics
Artemis Therapeutics was founded in 2017.
Artemis Therapeutics is headquartered in New York, United States. It is registered at New York, New York, United States.
Annual revenue of Artemis Therapeutics is $311K as on Dec 31, 2022.
Cameo is a Python library that supports the strain design process in metabolic engineering. It offers a modular framework for simulations, design methods, and high-level APIs to compute strategies for host organisms. Developers can create custom workflows, while users access tools for pathway prediction and gene knockout optimization. Associated with the Novo Nordisk Foundation Center for Biosustainability, it aids research in biotechnology applications.
Artemis Therapeutics's top competitors include Jaguar Health, 60 Degrees Pharmaceuticals and ACE Pharmaceuticals.
Artemis Therapeutics offers Cameo Library and Pathway Predictor.